Major Corporate & Financial Developments
TD SYNNEX (SNX) posted strong fiscal Q1 results with revenue reaching $14.5 billion and non‑GAAP EPS of $2.80, reinforcing its robust growth and regional performance.
Equifax (EFX) released its 2024 Security Annual Report highlighting record cybersecurity achievements in countering 15 million daily threats, underscoring its market resilience.
AV Awarded Major Contract – through its subsidiary Telerob, AV (AVAV) secured a deal to deliver 41 advanced uncrewed ground vehicles to the German Federal Armed Forces, with initial deliveries set for summer 2025.
CMB.TECH (CMBT) reported strong financial results for 2024, with Q4 profit of USD 93.1 million and full‑year profit of USD 870.8 million, alongside a contract backlog surge to USD 2.94 billion.
STMicroelectronics (STM) detailed key AGM resolutions, including a proposed cash dividend of US$0.36 per share and board changes set for its May 2025 meeting in Amsterdam, highlighting its evolving corporate governance.
Energy, Mining & Industrial Developments
Excelerate Energy (EE) finalized a transformative acquisition of New Fortress Energy’s Jamaica business for $1.055 billion, positioning itself as the exclusive LNG platform operator in Jamaica.
TotalEnergies (TTE), Equinor, and Shell advanced the Northern Lights carbon capture project, aiming to store over 5 million tons of CO₂ per year by 2028 and drive emissions reduction.
EMX Royalty (EMX) announced a significant copper and gold discovery at Serbia’s Timok project, identifying 2.81 million tonnes of copper with promising gold upside.
The Metals Company (TMC) plans to apply for deep‑sea mining permits under U.S. regulations after investing over $500 million to develop nodule resources in the Clarion Clipperton Zone.
Nexa Resources (NEXA) reported its 2024 Year‑End Mineral Reserves update for operations in Peru and Brazil, with Proven and Probable Reserves of 110.3 million tonnes containing 4,075kt of zinc, driven by successful infill drilling.
B2Gold Corp. (BTG) unveiled an updated technical report for its Goose Project, Nunavut, outlining an initial mine life of approximately 9 years and anticipated production of 2.3M ounces of gold over the period.
Empire Petroleum (EP) reported Q4 and full‑year 2024 results with a 22% increase in Q4 oil production to 1,581 Bbl/d and total production at 2,356 Boe/d, despite a net loss of $16.2 million.
Sustainability & Strategic Partnerships
IFF (IFF) and Kemira launched their joint venture, Alpha Bio, with a commitment of €130 million to boost renewable biobased material production, reinforcing a green growth trajectory.
Technological & Digital Innovations
Workday (WDAY) integrated Evisort’s AI‑powered contract intelligence into its platform, enabling transformative Contract Intelligence and Lifecycle Management products.
IBM (IBM) broadened its as‑a‑service portfolio with IBM Storage Ceph as a Service, streamlining on‑premises infrastructure management for enterprises.
Zebra Technologies (ZBRA) partnered with Merck KGaA to develop a handheld reader that integrates the M‑Trust™ platform with advanced mobile computing, enhancing product verification.
Pony AI Inc. (PONY) expanded its fully driverless commercial Robotaxi services in Shenzhen’s Nanshan District, marking a significant milestone in autonomous mobility commercialization.
Ascent Solar Technologies (ASTI) received an order to revise its space solar products design for beamed power, with its CIGS photovoltaic technology set to drive enhanced performance for space-based solar arrays.
Medical & Biotech Advances
Merck (MRK) announced positive Phase 3 trial results in metastatic non‑small cell lung cancer, demonstrating noninferior pharmacokinetics and improved treatment efficiency.
Beam Therapeutics (BEAM) received FDA clearance for its IND application for BEAM‑302, marking a significant advance in its liver‑targeting base editing approach.
Tempest Therapeutics (TPST) reported key 2024 milestones, with its lead drug Amezalpat earning Orphan Drug and Fast Track designations and progressing into a Phase 3 trial with Roche.
Portage Biotech (PRTG) presented promising preclinical data for PORT‑7 in mesothelioma, showing over 90% tumor growth inhibition with an anti‑PD1 combination, paving the way for a first‑in‑human trial.
Financial & Strategic Insights
Abacus Global Management (ABL) delivered robust Q4 and full‑year 2024 results, with full‑year revenue surging 69% to $111.9 million driven by increased policy originations and capital deployment.
GameStop (GME) announced the pricing of $1.3 billion of convertible senior notes due 2030, with an initial conversion price of $29.85 per share, a move expected to bolster its balance sheet and support Bitcoin acquisition initiatives.
Aviation & Transportation Developments
Sky Harbour Group (SKYH) reported record Q4 and 2024 results, securing a new hangar campus lease at King County International Airport – Boeing Field, while expanding its presence with new campuses in Phoenix, Dallas, and Denver.
